FDA Investigator Timothy G Philips
Timothy G Philips has inspections in 4 countries as of 01 Sep 2023. Timothy G Philips has collaborated with a combined 1249 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
13
Last Inspection Date:
01 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
United Kingdom of Great Britain and Northern Ireland,
Italy,
Germany
Co-Investigator(s):
A Williams,
Aaron L Dunbar,
Aimee J Edwin,
Alison A Nicoli,
Alison A Stone,
Annabelle Crusan, D,VM,
April L Brown,
April L Young,
Benjamin J Dastoli,
Benjamin W Anderson,
Billi Jom Johnson,
Carolyn A Warren,
Catherine J Laufmann,
Christina L Bigham,
Demetria L Lueneburg,
Douglas W Atkins,
Eric M Padgett,
Evelyn Taha,
Harperd,
Jaclyn N Munsch,
James A Beaulieu,
James D Planchon,
Janis R Armedoriz,
Jay V Jariwala,
Jennifer S Ness,
Jessica L Johnson,
Jocelyn M Muggli,
Joey C West,
Joseph D Gong,
Joseph M Edwin,
Karen M Montgomery (KMM),
Kellie L Thommes, RN,
Kellie L Westerbuhr,
Kimberly Lewandowski Walker,
Kristy E Zuroski,
Kyle J Mccracken,
Laiza V Garcia,
Marie A Fadden,
Marissa S Henning,
Marissa S Steinhagen,
Mary A Millner,
Maryam Tabatabaie,
Melanie W Pishnery,
Melissa I Michurski,
Michael J Nerz,
Nicole C Victoria, PhD,
Norman Wong,
Paul M Kawamoto,
Ralph Jerndal,
Rhonda L Mecl,
Rhonda L Meel,
Richard Jay Tucker, RS,
Richard L Rutherford,
Robert G Ruff,
Rosanna M Goodrich,
Ryan J Benedict,
Shannon M Berg,
Sharon L Matson,
Stephen D Eich,
Susan A Atcher,
Susan M Atcher,
Susan M Matthias,
Tania E Vizcaino,
Timothy R Marrs,
Tony T Yang,
Tyler R Courtney,
Victor Spanioli,
Wanda J Torres,
William D Tingley,
Yehualashet A Gessesse
Timothy G Philips's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2007 | FDA 483 | Medtronic Neuromodulation - Form 483, 2007-01-24 |
January, 2007 | EIR | Medtronic Neuromodulation - EIR, 2007-01-24 |
June, 2006 | FDA 483 | Medtronic Neuromodulation - Form 483, 2006-06-22 |
January, 2000 | FDA 483 | Boston Scientific Corporation - Form 483, 2000-01-14 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more